Vanguard Group Inc Yumanity Therapeutics, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.5 - $1.87 $33,918 - $42,284	-22,612 Reduced 7.94%	262,343 $412,000
Q1 2022 May 13, 2022	SELL	$0.97 - $3.27 $6,498 - $21,905	-6,699 Reduced 2.3%	284,955 $427,000
Q4 2021 Feb 14, 2022	SELL	$2.81 - $10.48 $7,927 - $29,564	-2,821 Reduced 0.96%	291,654 $863,000
Q3 2021 Nov 12, 2021	BUY	$8.3 - $12.04 $9,121 - $13,231	1,099 Added 0.37%	294,475 $3.04 Million
Q2 2021 Aug 13, 2021	BUY	$11.27 - $19.64 $3.31 Million - $5.76 Million	293,376 New	293,376 $3.42 Million

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.